Figure 4From: Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer KIF26B knockdown inhibits cancer cell proliferation. Western blot analysis of KIF26B protein expression in stable knockdown RKO and HT29 cell lines. Grayscale values were evaluated (n = 3, *P <0.05) (A). Expression of proliferation-related genes was inhibited in KIF26B knockdown cells according to real-time PCR analysis (n = 3; *P < 0.05) (B). Effects of KIF26B knockdown on cell growth was evaluated by Cell Counting Kit-8 assays (C) and plate colony formation assays (D) (n = 3; *P < 0.05).Back to article page